...
首页> 外文期刊>ABCD. Arquivos Brasileiros de Cirurgia Digestiva (So Paulo) >BIODEGRADABLE BILIARY STENTS: A NEW APPROACH FOR THE MANAGEMENT OF HEPATICOJEJUNOSTOMY STRICTURES FOLLOWING BILE DUCT INJURY. PROSPECTIVE STUDY
【24h】

BIODEGRADABLE BILIARY STENTS: A NEW APPROACH FOR THE MANAGEMENT OF HEPATICOJEJUNOSTOMY STRICTURES FOLLOWING BILE DUCT INJURY. PROSPECTIVE STUDY

机译:可生物降解的胆管:胆管损伤后肝硬化术狭窄的新方法。前瞻性研究

获取原文

摘要

Background: Once a biliary injury has occurred, repair is done by a hepaticojejunostomy. The most common procedure is to perform a dilatation with balloon with a success of 70 %. Success rates range using biodegradable stents is from 85% to 95%. Biodegradable biliary stents should change the treatment of this complication. Aim: To investigate the use of biodegradable stents in a group of patients with hepaticojejunonostomy strictures. Methods: In a prospective study 16 biodegradable stents were placed in 13 patients with hepaticojejunostomy strictures secondary to bile duct repair of a biliary surgical injury. Average age was 38.7 years (23-67), nine were female and four male. All cases had a percutaneous drainage before at the time of biodegradable stent placement. Results: In one case, temporary haemobilia was present requiring blood transfusion. In another, pain after stent placement required intravenous medication. In the other 11 patients, hospital discharge was the next morning following stent placement. During the patient?′s follow-up, none presented symptoms during the first nine months. One patient presented significant alkaline phosphatase elevation and stricture recurrence was confirmed. One case had recurrence of cholangitis 11 months after the stent placement. 84.6% continued asymptomatic with a mean follow-up of 20 months. Conclusion: The placement of biodegradable stents is a safe and feasible technique. Was not observed strictures caused by the stent or its degradation. It could substitute balloon dilation in strictures of hepaticojejunostomy.
机译:背景:一旦发生胆道伤害,修复由肝脏jejunostomy完成。最常见的程序是与气球进行扩张,成功为70%。使用可生物降解支架的成功率范围为85%至95%。可生物降解的胆管应改变这种并发症的治疗。目的:探讨一组肝病junonostomy术患者中生物降解支架的使用。方法:在预期研究中,16种可生物降解的支架置于13例肝癌术患者中,继发于胆汁手术损伤的胆管修复。平均年龄为38.7岁(23-67),九是女性和四名男性。在可生物降解的支架放置之前,所有病例均具有经皮排水。结果:在一种情况下,需要输血的临时血液血症。在另一个,支架放置后的疼痛需要静脉内用药。在另外11名患者中,医院出院是第二天早上在展示楼后。在病人期间?在前九个月内随访,没有呈现症状。一名患者提出了显着的碱性磷酸酶升高,并确认了狭窄复发。一例患者在支架放置后11个月内复发胆管炎。 84.6%持续无症状,平均随访20个月。结论:可生物降解支架的放置是一种安全可行的技术。未观察到由支架或降解引起的狭窄。它可以替代肝脏jejunostomy的狭窄的球囊扩张。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号